Following are publications for which I provided professional medical writing support.

Data manuscripts

Pepose JS, Qazi MA, Devries DK. Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity. Clin Ophthalmol. 2019;13:571–579.
https://www.dovepress.com/longitudinal-changes-in-dry-eye-symptoms-and-signs-following-lifitegra-peer-reviewed-fulltext-article-OPTH

Roca-Ferrer J, Pujols L, Pérez-González M, Alobid I, Callejas B, Vicens-Artés S, Fuentes M, Valero A, Picado C, Castor D, Nguyen D, Mullol J. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers. Allergy Asthma Clin Immunol. 2018;14:86.
https://aacijournal.biomedcentral.com/track/pdf/10.1186/s13223-018-0311-4

Gadde KM, Vetter ML, Iqbal N, Hardy E, Öhman P; DURATION-NEO-2 study investigators. Efficacy and safety of auto injected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study. Diabetes Obes Metab. 2017;19:979–988.
http://onlinelibrary.wiley.com/doi/10.1111/dom.12908/pdf

Baxter R, Eaton A, Hansen J, Aukes L, Caspard H, Ambrose CS. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49 years. Vaccine. 2017;35:1254-1258.
https://www.sciencedirect.com/science/article/pii/S0264410X17301287

Lundkvist P, Pereira MJ, Katsogiannos P, Sjöström CD, Johnsson E, Eriksson JW. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes Obes Metab. 2017;19:1276-1288.
https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.12954

McLean HQ, Caspard H, Griffin MR, Poehling KA, Gaglani M, Belongia EA, Talbot HK, Peters TR, Murthy K, Ambrose CS. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season. Vaccine. 2017;35:2685-2693.
https://www.sciencedirect.com/science/article/pii/S0264410X17304371

Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP; OPUS-2 Investigators. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology. 2015;122:2423–2431.
http://www.aaojournal.org/article/S0161-6420(15)00777-0/pdf

Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA; IMPACT-HAP Study Group. Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study. Crit Care. 2014;18:R118.
https://ccforum.biomedcentral.com/track/pdf/10.1186/cc13914

Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis. 2013;13:561.
https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/1471-2334-13-561

Dahlin LB, Bainbridge C, Szczypa PP, Cappelleri JC, Guérin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: the surgeon’s perspective. Eur Orthop Traumatol. 2012;3:25–30.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337993/pdf/12570_2012_Article_91.pdf

Bainbridge C, Dahlin LB, Szczypa PP, Cappelleri JC, Guérin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3:31-41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338000/pdf/12570_2012_Article_92.pdf

Posters
Presented at: Psych Congress; October 25-28, 2018; Orlando, FL.
Click here to view poster.

Presented at: IDWeek 2016; October 26-30, 2016; New Orleans, LA.
Click here to view poster.

Presented at: The American Diabetes Association’s 76th Scientific Sessions (ADA 2016); June 10–14, 2016; New Orleans, LA.
Click here to view poster.

Presented at: The 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) / 27th International Congress of Chemotherapy (ICC) Congress; May 7-10, 2011; Milan, Italy.
Click here to view poster.

Oral presentations
Presented at: The American Academy of Optometry (AAO) 2015 Annual Meeting; October 7–10, 2015; New Orleans, LA.
Click here to view slides.

Presented at: The European Federation of National Associations of Orthopaedics and Traumatology (EFORT) Congress; June 1–4, 2011; Copenhagen, Denmark.
Click here to view slides.

Review articles

Araújo-Vilar D, Santini F. Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest. 2019;42:61-73.
https://link.springer.com/content/pdf/10.1007%2Fs40618-018-0887-z.pdf

Salles MJ, Zurita J, Mejía C, Villegas MV; Latin America Working Group on Bacterial Resistance. Resistant gram-negative infections in the outpatient setting in Latin America. Epidemiol Infect. 2013;141:2459–2472.
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/C0443376314F41C0B79C6F4BFC815301/S095026881300191Xa.pdf

Continuing medical education

CME Slide Deck, Multidrug-Resistant Infections, 2010.
Click here to view slides.

Some document types not included for confidentiality reasons.